CLARIANT MAY divest or spin most distant its businesses in pharmaceutical and harvest protection fine chemicals after their poor performance helped douse the company m red ink last year.

CLARIANT MAY divest or spin most distant its businesses in pharmaceutical and harvest protection fine chemicals after their poor performance helped douse the company m red ink last year.
The company has decided to transfer into separate legal entities its pharma and custom synthesis activities. Its electronic materials and masterbatch businesses will also be given a similar legal status.
"This measure will give us greater strategic flexibility with these four businesses," says a Clariant official. "They will either stay with the company or we will possibly find a

...